Cob Guillén E, Cohen-Rosenstock S, Piedra CW

Language: Spanish
References: 13
Page: 1-6
PDF size: 251.49 Kb.

ABSTRACT

Autoimmune hepatitis is a chronic hepatopathy of unknown origin, characterized by the presence of hypergammaglobulinemia and interface histology. Due to the absence of serological markers and the great heterogeneity of its clinical, laboratory and histological characteristics it is difficult to make a correct diagnosis. is pathology has a global distribution affecting any age, both sexes and all ethnic groups. Clinical manifestations may present as fulminant hepatitis. Due to its challenging diagnosis, autoimmune hepatitis should be considered as a differential diagnosis in all patients with chronic liver disease associated with negative viral serologies without metabolic or toxic disorders. is review allows medical personnel to be informed of the need to become familiar with this disease and thus make better diagnoses to benefit their patients.

REFERENCES

1. Liberal R Mieli-Vergani G Vergani D. Autoimmune hepatitis: From mechanism to therapy. Rev Clin Esp. 2016;216(7):372-383.

2. Díaz-Ramírez GS Marín-Zuluaga JI Donado- Gómez JH Muñoz-Maya O Santos-Sánchez O Restrepo-Gutiérrez JC. Caracterización de los pacientes con hepatitis autoinmune de un hospital universitario, Medellín-Colombia: estudio de cohorte. Gastroenterol Hepatol. 2017.

3. Manns MP Lohse AW Vergani D. Autoimmune hepatitis – Update 2015. J Hepatol. 2015;62:S100-S111.

4. Gatselis NG Zachou K Koukoulis GK Dalekos GN. Autoimmune hepatitis, one disease with many faces: Etiopathogenetic, clinico-laboratory and histological characteristics. World J Gastroenterol. 2015;7;21(1):60-83.

5. Yang F Wang Q Bian Z Ren L Jia J Ma X. Autoimmune hepatitis: East meets west. J Gastroenterol Hepatol. 2015;30(8):1230-1236.

6. de Boer YS van Nieuwkerk MJ Witte BI Mulder CJJ Bauma G Bloemena E. Assessment of the histopathological key features in autoimmune hepatitis. Histopathology. 2015; 66(3):351–362.

7. Brenes-Pino F. Histología de la biopsia hepática, enfoque para el clínico. Acta Med Costarric. 2008; 50(3):19-22.

8. Zachou K Muratori P Koukoulis GK et al. Review article: autoimmune hepatitis – current management and challenges. Aliment Pharmacol Ther. 2013;38:887–913.

9. Czaja AJ, Donaldson PT. Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis. Am J Gastroenterol. 2002;97:2051-2057.

10. Czaja AJ. Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets. Aliment Pharmacol Ther. 2014;40(3):261-279.

11. Czaja AJ. (2017). Hepatitis Autoinmune. En Sleisenger y Fordtran’s gastrointestinal and liver disease. (pp. 1496-1510). El Sevier Saliders. Philadelphia, PA. 10th Edition.

12. Chazouillères O Dalekos G Drenth J et al. EASL Clinical Practice Guidelines: Autoimmune hepatitis. J Hepatol. 2015;63:971–1004.

13. Alvarez E Berg PA Bianchi FB et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31(5):929-938.